sinc
start
epidem
million
peopl
die
million
infect
human
immunodefici
infect
primari
manner
transmiss
occur
mucos
surfac
includ
oral
cervicovagin
rectal
mucos
epithelia
predominantli
target
cell
associ
adapt
immun
respons
particular
cell
resid
primarili
lymph
node
gastrointestin
tract
immun
activ
induc
infect
provid
cell
target
viral
replic
increas
cell
turnov
deplet
eventu
initi
viciou
cycl
uncontrol
viral
replic
stage
infect
fail
immun
system
allow
reemerg
preexist
latent
pathogen
burden
immun
respons
format
viciou
cycl
lead
exhaust
adapt
immun
system
eventu
progress
acquir
immun
defici
syndrom
aid
although
adapt
immun
respons
play
larg
role
pathogenesi
progress
aid
mount
evid
suggest
innat
immun
system
directli
indirectli
impact
diseas
progress
myeloid
cell
innat
immun
system
includ
monocyt
macrophag
dendrit
cell
dc
also
target
viru
earli
stage
infect
evid
suggest
dc
initi
transmit
across
mucos
barrier
exact
time
cours
diseas
progress
difficult
predict
owe
variat
factor
host
genet
environ
two
four
week
may
pass
follow
initi
exposur
full
activ
adapt
immun
respons
initi
time
viru
replic
spread
without
much
control
via
infect
cell
unregul
viral
replic
suggest
failur
innat
immun
mechan
natur
killer
cell
normal
control
viral
infect
whose
cytolyt
function
compromis
viremia
rhesu
macaqu
rapid
upregul
inflammasom
follow
simian
immunodefici
viru
siv
infect
shown
respons
dysregul
innat
acquir
immun
respons
final
activ
cell
dramat
decreas
viremia
howev
stage
infect
viru
alreadi
establish
reservoir
persist
lowlevel
replic
mucosaassoci
lymphat
tissu
particular
gut
host
becom
chronic
infect
unclear
whether
innat
immun
contribut
reduc
viral
replic
regul
immun
activ
one
critic
compon
innat
respons
includ
famili
small
antimicrobi
peptid
term
defensin
defensin
cation
peptid
character
structur
three
intramolecular
cysteinedisulfid
bond
vertebr
defensin
compris
subfamili
differ
size
pattern
disulfid
linkag
subdivid
two
class
myeloid
enter
myeloid
consist
human
neutrophil
peptid
hnp
resid
within
primari
granul
neutrophil
synthes
bone
marrow
tabl
conflict
report
presenc
hnp
lymphocyt
cell
type
certain
circumst
genuin
express
may
occur
presenc
seem
rather
consequ
pinocyt
uptak
enter
human
defensin
hd
produc
paneth
cell
pc
crypt
small
intestin
also
synthes
epitheli
cell
genitourinari
tract
human
hbd
express
skin
mucos
epitheli
cell
line
organ
urinari
tract
kidney
trachea
tabl
numer
hbd
describ
genom
level
protein
level
includ
also
express
monocyt
macrophag
dc
unlik
possess
cyclic
structur
exist
certain
nonhuman
primat
speci
notabl
old
world
monkey
macaqu
chimpanze
gorilla
rhesu
rtd
exhibit
strong
antimicrobi
activ
includ
antihiv
activ
primarili
synthes
bone
marrow
express
neutrophil
monocyt
pc
tabl
strong
antiinflammatori
activ
describ
although
human
chimpanze
possess
ancestr
gene
express
due
stop
codon
preprocod
sequenc
gene
howev
chemic
synthes
ancestr
human
rtd
peptid
retrocyclin
rc
shown
great
promis
research
antivir
therapi
drug
develop
regulatori
immun
function
defensin
serv
strong
microbicid
agent
also
aid
regul
certain
facet
adapt
immun
system
includ
chemotaxi
cell
monocyt
matur
dc
hand
downregul
immun
respons
interfer
signal
ablat
immun
activ
brief
review
focu
role
defensin
pathogenesi
diseas
progress
effector
innat
immun
respons
modul
adapt
immun
respons
defensin
affect
wide
rang
respons
infect
pathogen
microb
among
inhibit
infect
shown
mediat
block
viral
entri
cell
interf
critic
step
viral
replic
follow
infect
vitro
prevent
entri
cell
interf
bind
viral
cell
also
inhibit
replic
via
disrupt
protein
kinas
c
signal
pathway
hivinfect
cell
howev
bind
hnp
envelop
compromis
presenc
serum
due
high
bind
affin
hnp
serum
protein
suggest
hnp
may
effect
bind
virion
circul
blood
nonetheless
breast
milk
adjust
hiv
rna
quantiti
women
higher
concentr
less
like
transmit
viru
child
compar
women
lower
concentr
thu
antihiv
activ
like
import
region
low
concentr
serum
protein
mucos
surfac
abil
block
viral
entri
attenu
presenc
serum
protein
research
demonstr
remain
activ
bind
regardless
presenc
serum
protein
abil
limit
viral
infect
may
attribut
higher
bind
affin
serum
protein
compar
uniqu
properti
enabl
interact
differ
region
bind
structur
properti
differ
dramat
may
contribut
observ
differ
hnp
activ
remain
activ
vitro
effect
may
biolog
neglig
vivo
due
scarc
amount
produc
neutrophil
although
neutrophil
promin
repres
hivmedi
gastroentropathi
recent
shown
reduc
tight
junction
express
intestin
epitheli
cell
promot
hiv
travers
ad
complex
hnp
role
hiv
infect
process
direct
effect
transmiss
gastrointestin
gi
tract
genit
mucosa
complex
establish
infect
within
hour
travers
mucos
barrier
abil
innat
immun
factor
mount
vigor
immedi
respons
may
key
success
preserv
intact
mucos
barrier
limit
viral
spread
tissu
unlik
disrupt
intestin
epitheli
cell
barrier
intestin
pc
constitut
secret
protect
host
invad
pathogen
maintain
commens
microbi
commun
clinic
signific
role
well
document
crohn
diseas
character
paneth
cell
dysfunct
reduc
product
alter
resid
microbiota
subsequ
inflamm
cellmedi
immun
respons
upregul
colorect
mucosa
observ
patient
possibl
respons
intestin
inflamm
similarli
respons
bacteri
vaginosi
synthesi
hbd
increas
agreement
role
defensin
protect
mucos
barrier
demonstr
direct
inhibitori
effect
entri
purifi
peripher
blood
lymphocyt
bind
viral
receptor
serumfre
condit
vitro
howev
ding
colleagu
show
antivir
effect
hiv
infect
serumfre
primari
lymphocyt
cultur
result
defensinmedi
cell
death
independ
hiv
receptor
moreov
treatment
enhanc
hiv
infect
cell
serumfre
condit
vitro
absenc
defensinmedi
cell
death
recent
research
find
mous
enter
adenoviru
model
reveal
paneth
cell
defensin
requir
protect
neutral
antibodi
respons
oral
viral
infect
suggest
interact
enter
defensin
adapt
immun
respons
apart
defensintrigg
enhanc
immunogen
viral
particl
format
larger
aggreg
enter
defensin
may
chemoattract
immun
cell
alter
helper
b
cell
function
studi
need
determin
enter
defensin
similarli
recruit
cell
gut
therebi
induc
gutassoci
hiv
reservoir
one
intrigu
area
research
warrant
investig
role
mitig
effect
diseas
progress
siv
infect
human
anim
respect
induc
inflamm
upregul
proinflammatori
cytokin
chemokin
express
increas
intestin
permeabl
gi
tract
understand
caus
consequ
continu
immun
activ
result
inflamm
associ
pathogenesi
becom
focu
current
research
effort
patholog
chang
occur
acut
chronic
stage
infect
activ
immun
respons
implic
develop
enteropathi
characterist
exampl
infect
polar
intestin
epitheli
cell
variou
strain
led
upregul
turn
led
disrupt
tight
junction
protein
increas
permeabl
produc
monocytederiv
macrophag
impair
barrier
function
cell
induc
apoptosi
similarli
upregul
sivinfect
macaqu
promot
apoptosi
intestin
epitheli
cell
human
upregul
intestin
stimul
pc
degranul
subsequ
releas
may
promot
barrier
integr
nevertheless
could
increas
viral
transmiss
rate
due
increas
viral
uptak
sivinfect
macaqu
enter
express
increas
gut
stage
infect
compar
control
suggest
innat
defens
attempt
compens
viralinduc
epitheli
damag
effect
mucos
cell
deplet
intestin
barrier
compromis
microb
normal
inhabit
gut
cross
epithelium
circul
system
immun
system
microbi
transloc
partli
respons
persist
immun
activ
associ
diseas
progress
continu
immun
activ
eventu
exhaust
resourc
replenish
deplet
cell
popul
promot
hiv
diseas
progress
synthesi
enter
defensin
certainli
function
protect
host
prevent
intestin
barrier
disrupt
howev
lack
inform
potenti
immunolog
impact
peptid
decreas
enter
defensin
protein
level
observ
sivinfect
macaqu
advanc
stage
infect
correl
increas
opportunist
bacteri
infect
sivinfect
sooti
mangabey
sm
natur
host
siv
express
level
elev
compar
sivinfect
macaqu
lack
diseas
progress
despit
high
level
viral
replic
observ
sm
compar
macaqu
part
attribut
activ
downregul
inflamm
sm
respons
bacteri
infect
hnp
reduc
proinflammatori
cytokin
concentr
vivo
blood
mice
recent
studi
demonstr
retain
antimicrobi
activ
releas
apoptot
neutrophil
inhibit
uptak
mrna
translat
macrophag
reduc
inflammatori
exud
format
vitro
howev
evid
elev
gastrointestin
concentr
hiv
patient
lack
hnpmediat
control
macrophagedriven
inflamm
may
contribut
develop
continu
inflamm
seen
hiv
gastroenteropathi
antimicrobi
activ
combin
effect
immun
regul
respons
necessit
investig
complex
relationship
peptid
pathogenesi
predominantli
express
epitheli
cell
therefor
serv
first
line
defens
invad
pathogen
mucos
surfac
skin
synthesi
hbd
regul
regul
respons
innat
adapt
immun
hbd
product
secret
stimul
microb
releas
cytokin
includ
effect
pathogenesi
tradit
center
oral
environ
rate
oral
transmiss
significantli
less
vagin
rectal
transmiss
detect
level
routin
found
normal
oral
epithelium
adult
addit
recombin
shown
directli
inactiv
recent
studi
tonsil
epitheli
cell
demonstr
simultan
bind
heparan
sulfat
proteoglycan
epitheli
cell
hbd
viral
initi
cointern
defensin
virion
endosom
result
reduc
hiv
infect
follow
viral
entri
also
block
replic
prevent
accumul
revers
transcript
product
moreov
exert
activ
tropic
hiv
infect
mothertochild
transmiss
commonli
occur
oral
gastrointestin
epithelia
fetal
infant
oral
epitheli
tissu
lack
hbd
express
allow
transmigr
virion
within
oral
mucosa
increas
risk
transmiss
cellfre
cellassoci
viral
particl
transmigr
fetal
adult
oral
epithelium
infect
permiss
cell
highlight
potent
antivir
activ
hbd
adult
oral
environ
cocultur
experi
epitheli
cell
stromal
fibroblast
cell
shown
epithelialderiv
antimicrobi
factor
protect
cell
hiv
infect
endometri
epitheli
cell
eec
significantli
overexpress
six
gene
associ
activ
abund
secretori
leukocyt
peptidas
inhibitor
increas
gene
express
observ
eec
potent
inhibit
infect
cell
howev
studi
also
show
absenc
epitheli
cell
stromal
fibroblast
markedli
enhanc
hiv
infect
cell
highlight
import
epitheli
cell
barrier
apart
direct
antimicrobi
activ
promin
immunomodulatori
activ
includ
recruit
immun
cell
induct
antivir
protein
first
describ
chemotact
activ
recruit
immatur
dc
also
memori
cell
bind
chemokin
receptor
later
chemotaxi
induc
myeloid
cell
replic
inhibit
postentri
pbmc
treat
document
inhibit
accumul
revers
transcript
product
hivsiv
infect
select
target
deplet
cell
peripher
blood
popul
restor
maintain
antiretrovir
treatment
howev
interact
receptor
induc
express
antivir
protein
host
restrict
factor
apolipoprotein
b
mrnaedit
enzymecatalyt
polypeptidelik
enzym
known
prevent
complet
synthesi
revers
transcript
express
dc
memori
cell
indic
potenti
import
role
prevent
infect
target
cell
upregul
addit
innat
antivir
factor
effect
includ
induct
proinflammatori
cytokin
also
antiinflammatori
cytokin
suppress
product
cell
thu
alter
physiolog
concentr
like
multitud
effect
local
homeostasi
also
influenc
presenc
defensin
synthesi
shown
associ
mainten
gi
health
follow
pathogen
infect
develop
intestin
disord
constitut
express
intestin
epithelium
colon
express
induc
colon
duodenum
follow
pathogen
exposur
infect
extent
microbi
transloc
occur
correl
amount
inflamm
gi
epitheli
damag
one
propos
reason
increas
intestin
damag
patient
progress
loss
cell
subsequ
diminish
control
resid
microbiota
epitheli
cell
neutrophil
cell
secret
cytokin
regul
mucos
immun
respons
promot
secret
antimicrobi
peptid
includ
siv
infect
deplet
cell
ileal
mucosa
result
increas
microbi
transloc
loss
cell
could
lead
reduc
innat
defensin
level
trigger
addit
alter
immunolog
signal
therebi
exacerb
epitheli
damag
transloc
microb
ultim
induc
system
immun
activ
individu
similar
enteropathi
inflamm
induc
irrit
bowel
diseas
ulcer
coliti
result
damag
intestin
epithelium
subsequ
transloc
microb
express
increas
patient
irrit
bowel
diseas
ulcer
coliti
convers
express
decreas
ulcer
coliti
crohn
diseas
observ
variat
intestin
hbd
express
highlight
need
futur
studi
thoroughli
investig
underli
mechan
respons
regul
antimicrobi
synthesi
respons
gi
disord
pathogen
infect
preexist
genit
infect
affect
inflammatori
molecul
secret
hbd
synthesi
downstream
effect
diseas
progress
women
human
papillomaviru
hpv
proinflammatori
cytokin
level
elev
compar
women
without
hpv
similarli
recent
studi
found
greater
escherichia
coli
inhibitori
activ
higher
concentr
cervicovagin
lavag
cvl
associ
increas
risk
acquisit
possibl
due
increas
mucos
inflamm
analog
studi
observ
women
seroconvert
like
greater
e
coli
bactericid
activ
higher
concentr
vagin
fluid
prior
seroconvers
compar
women
seroconvert
convers
women
cervic
intraepitheli
neoplasia
result
hpv
infect
significantli
greater
concentr
proinflammatori
cytokin
exhibit
lower
level
cvl
compar
control
moreov
defensinmedi
recruit
innat
adapt
immun
cell
respons
preexist
genit
infect
may
facilit
dissemin
replic
increas
number
avail
target
cell
although
hbd
exhibit
activ
studi
suggest
multitud
factor
femal
genit
tract
includ
differ
vagin
microbiom
presenc
addit
sexual
transmit
infect
may
alter
role
hbd
vivo
discrep
emphas
need
research
complex
interact
genit
infect
innat
immun
adapt
immun
pathogenesi
variabl
express
hbd
epitheli
cell
differ
origin
ultim
impact
peptid
function
protect
host
infecti
agent
exhibit
strong
activ
oral
epitheli
cell
gi
tract
associ
increas
secret
proinflammatori
molecul
may
promot
local
inflamm
viral
transmiss
futur
research
effort
relationship
hbd
focu
elucid
mechan
involv
reduc
virion
infect
oral
environ
assess
potenti
limit
spread
epitheli
tissu
explor
human
genom
sequenc
novel
hbd
date
identifi
genom
transcript
level
human
although
four
hbd
well
character
protein
function
level
two
isoform
found
exclus
express
human
epididymi
also
known
appear
similarli
predominantli
express
male
genit
tract
recombinantli
produc
exhibit
antimicrobi
activ
e
coli
suggest
peptid
may
also
promot
host
protect
innat
immun
addit
role
may
assign
sperm
matur
transport
impact
male
fertil
suggest
natur
express
old
world
monkey
cyclic
peptid
identifi
mammal
six
isoform
isol
neutrophil
bone
marrow
nonhuman
primat
like
defensin
rtd
potent
antimicrobi
activ
compar
activ
rel
insensit
salt
dival
cation
serum
although
human
bone
marrow
express
mrna
similar
mrna
precursor
rtd
defensin
peptid
synthes
natur
use
solidphas
peptid
synthesi
research
synthes
homolog
rtd
peptid
refer
retrocyclin
accord
human
pseudogen
sequenc
addit
antimicrobi
possibl
proteaseinhibit
activ
also
exhibit
immunomodulatori
properti
unlik
suppress
secret
proinflammatori
cytokin
inhibit
activ
mapk
pathway
treatment
mice
reduc
level
proinflammatori
cytokin
blood
leukocyt
correl
increas
surviv
bacteri
infect
anim
mice
expos
mous
sever
acut
respiratori
syndrom
sar
coronaviru
also
show
increas
surviv
associ
decreas
level
proinflammatori
cytokin
interestingli
viral
titer
remain
high
throughout
studi
suggest
increas
surviv
without
inactiv
viral
particl
may
also
inhibit
enzym
possibl
ad
immunosuppress
activ
protect
activ
uniqu
compar
defensin
stem
pronounc
suppress
proinflammatori
respons
rather
direct
interact
pathogen
excess
product
proinflammatori
cytokin
induc
exacerb
diseas
progress
potenti
mediat
respons
need
assess
hand
express
function
old
world
monkey
resist
may
causal
relationship
antiinflammatori
characterist
evalu
determin
peptid
reduc
inflamm
subsequ
epitheli
impair
result
infect
use
combat
hiv
human
natur
synthet
possess
activ
like
downmodul
inhibit
entri
tropic
howev
also
block
viral
replic
cdna
format
inhibit
tropic
indic
distinct
mechan
util
cyclic
acycl
defensin
key
differ
antiretrovir
immun
modulatori
activ
select
human
defensin
rhesu
highlight
figur
synthet
reduc
infect
prevent
format
provir
dna
block
envmedi
cell
fusion
furthermor
provid
protect
cell
cell
tropic
mtropic
strain
rc
inhibit
viral
entri
bind
viral
receptor
exhibit
strongest
bind
affin
compar
rc
studi
suggest
rtd
rc
reduc
infect
disrupt
viral
entri
instead
directli
inactiv
virion
observ
hnp
hbd
recent
research
focus
use
rc
congen
develop
microbicid
prevent
viral
transmiss
analogu
engin
enhanc
antivir
properti
analog
demonstr
greater
inhibitori
activ
test
use
microbicid
vagin
tissu
result
promis
quickdissolv
film
formul
show
activ
vitro
nontox
reproduct
tissu
remain
bioactiv
month
moreov
treatment
inhibit
pathogen
bacteria
vagin
tissu
associ
bacteri
vaginosi
condit
increas
suscept
simultan
maintain
benefici
microbi
commun
protect
host
infect
lack
toxic
vivo
compat
normal
vagin
microbiota
abil
inhibit
pathogen
bacteri
growth
make
ideal
peptid
microbicid
develop
research
develop
inexpens
microbicid
especi
import
countri
high
infect
rate
limit
resourc
topic
microbicid
prevent
transmiss
could
dramat
reduc
number
new
infect
death
result
aid
year
futur
investig
continu
assess
use
safe
effect
microbicid
eventu
transit
clinic
trial
defensin
compris
critic
compon
innat
immun
respons
exhibit
activ
broad
rang
pathogen
shape
normal
microbiota
modul
immun
respons
preferenti
target
cell
associ
adapt
immun
innat
immun
respons
critic
research
continu
explor
abil
defensin
limit
viral
transmiss
mediat
effect
diseas
progress
activ
defensin
work
sever
level
direct
inactiv
virion
inhibit
viral
entri
interfer
viral
replic
follow
cell
entri
increas
product
antivir
factor
facilit
cellular
commun
regul
adapt
respons
hand
immunomodulatori
action
defensin
may
also
impact
epitheli
barrier
function
therebi
contribut
hiv
dissemin
increas
uptak
hiv
via
stromal
fibroblast
recruit
suscept
target
cell
figur
sivinfect
macaqu
model
wellaccept
model
studi
hiv
pathogenesi
continu
employ
macaqu
model
siv
infect
combin
insight
gain
studi
diseas
defensin
synthesi
immunomodulatori
characterist
import
key
futur
progress
hiv
research
one
crucial
next
step
includ
research
develop
defensinbas
therapeut
success
use
topic
microbicid
reduc
transmiss
encourag
research
effort
must
continu
explor
effect
inexpens
way
decreas
rate
new
infect
target
immunomodulatori
action
defensin
gi
barrier
open
new
approach
limit
hiv
dissemin
diseas
progress
infect
patient
